“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. World Bulletin of Public Health 18 (January 11, 2023): 9–14. Accessed April 21, 2026. https://www.scholarexpress.net/index.php/wbph/article/view/1965.